Cyteir Therapeutics closes lower on first day of trading (NASDAQ:CYT)

Oncology-focused biotech firm Cyteir Therapeutics > ended lower on trading debut after rising as much as ~13.8% intraday Friday following an IPO priced at $18.00…
Read More